Skip to main content

Table 1 Patient and tumor characteristics at baseline (n = 12)

From: A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial)

Characteristic

No. of patients

Median age, year (range)

62, (31–74)

Gender: Male/Female

10/2

ECOG PS: 0/1

12/0

Clinical T classification

 

  cT3/cT4

12/0

Clinical N classification

 

  cN0/cN+

3/9

Clinical stage

 

  cStage IIA/IIIA/IIIB/IIIC

3/0/8/1

Histologic differentiation

 

  Well/Mod*

7/4

  1. *Well: well differentiated adenocarcinoma, Mod: moderately ;differentiated adenocarcinoma.